Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Des mains qui manipulent une boite de pétri

Neurotrials

Paris Brain Institute Early Clinical Development Unit

Comprised of highly qualified professionals from academia and industry, Neurotrials is a Contract Research Organization (CRO) offering a full range of services from medical writing to conducting studies. Neurotrials specializes in proof of concept trials (phases Ib and/or IIa) in neurology and psychiatry.

A single ecosystem

A single ecosystem

Neurotrials is based on a unique ecosystem within Paris Brain Institute and the Centre Hospitalo-Universitaire (CHU) of Ile-de-France (Assistance publique – Hôpitaux de Paris / APH-HP), comprising internationally renowned experts, numerous patients with various neurological pathologies, and leading-edge research technologies that accelerate the development of health products, thanks to innovative and reliable solutions, while controlling costs, based on standard operating procedures – Standard Operating Procedure (SOP) – and a rigorous quality assurance system.
 

"Neurotrials combines the scientific excellence of academia with the effectiveness of industry to optimize the development of health products at an early stage of development."

Louise-Laure MARIANI Director of Neurotrials and Medical Lead, MD, PhD, MCU-PH of Neuropharmacology

Neurotrials is based at Paris Brain Institute, where it collaborates with privileged partners for clinical studies that require it, such as:

  • The Centre for Clinical Investigation (CIC) dedicated to neuroscience,
  • The CENIR platform (Neuroimaging Center) and PANAM (Physiology and Analysis of Movement).
  • The DNA Biological Resource Centre and the Cell Biobank.

Neurotrials offers operational excellence in conducting and conducting Phase Ib/IIa clinical studies in brain pathology.

Pierre GEORGES FRANCOIS Clinical Operations Officer
Contact Neurotrials

Contact Neurotrials

For more information, contact neurotrials@icm-institute.org.

News that might interest you

Une fusée qui décolle
Paris Brain Institute launches the 2nd edition of NeurAL, its studio startup program dedicated to neuroscience
With support from the Anne and Claude Berda Foundation and from Indosuez Wealth Management, Paris Brain Institute is launching the second edition of NeurAL, its startup studio program.
07.01.2024 Research applications
Logo EBRAINS
Paris Brain Institute becomes associated member of EBRAINS AISBL
Paris Brain Institute is pleased to announce its membership to EBRAINS AISBL, a new digital research infrastructure (RI), created by the EU-funded Human Brain Project (HBP), to foster brain-related research.
10.13.2022 Research applications
Logo Wefight
Pierre Nectoux, co-founder of Wefight, named to the "30 Under 30" ranking by Forbes France magazine
Forbes France magazine unveiled in its latest issue the ranking of its fifth edition "30 Under 30". This ranking is dedicated to a new generation of entrepreneurs who disrupt the codes of their field: sports, finance, art, entertainment, environment...
04.13.2021 Research applications
Logo de Healthy Mind et Uptale
Healthy Mind and Uptale selected for STATION F's Future 40 ranking
On November 18, Station F unveiled the second edition of its Future 40 ranking. 2 startups hosted in our incubator iPEPS -The Healthtech Hub are included: Healthy Mind and Uptale.
11.18.2020 Research applications
Logo Scipio bioscience
Scipio bioscience raises €6.0 M Series A financing 
To develop and launch a kit dedicated to sample preparation for single-cell RNA-sequencing
03.20.2020 Research applications
Logo du World Economic Forum
In partnership with ICM, A joint FIA & EMOTIV tech experience leveraging Virtual Reality and real-time neuroinformatics to improve road safety will premiere in Davos next week
The World Economic Forum is held from January 23 to 26. Some 70 heads of state and government are expected to participate in this popular meeting of bosses from around the world.
01.23.2018 Research applications
See all our news